Abstract:Rationale: Developing an effective nanoplatform to realize 'multi-in-one' is essential to broaden the therapeutic potential of combination therapy. Exosomes are ideal candidates since their intrinsic abilities of integrating multiple contents and functions. However, only limited efforts have been devoted to engineering exosomes to integrate the needed properties, also considering the safety and yield, for tumor-targeted and efficient gene/chemo combination therapy.Methods: Herein, by manipulating the exosome membrane, blood exosomes with high abundance and safety are engineered as a versatile combinatorial delivery system, where the doxorubicin (Dox) and cholesterol-modified miRNA21 inhibitor (miR-21i) are co-embedded into the lipid bilayer of exosomes, and the magnetic molecules and endosomolytic peptides L17E are bind to the exosome membrane through ligand-receptor coupling and electrostatic interactions, respectively.Results: It is proved that such engineering strategy not only preserves their intrinsic features, but also readily integrates multiple properties of tumor targeting, efficient transfection and gene/chemo combination therapy into blood exosomes. The lipid bilayer structure of exosomes allows them to co-load Dox and miR-21i with high-payloads. Moreover, profiting from the integration of magnetic molecules and L17E peptides, the engineered exosomes exhibit an enhanced tumor accumulation and an improved endosome escape ability, thereby specifically and efficiently delivering encapsulated cargos to tumor cells. As a result, a remarkable inhibition of tumor growth is observed in the tumor-bearing mice, and without noticeable side effects.Conclusions: This study demonstrates the potential of engineered blood exosomes as feasible co-delivery nanosystem for tumor-targeted and efficient combination therapy. Further development by replacing the drugs combined regimens can potentially make this engineered exosome become a general platform for the design of safe and effective combination therapy modality.

Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy

The Antitumor Effect of Gene-Engineered Exosomes in the Treatment of Brain Metastasis of Breast Cancer.

Engineered Exosome-Based Drug Delivery System for Synergistic Cancer Therapy Via Autophagy Inhibition and Chemotherapy

Engineered exosomes as a natural nanoplatform for cancer targeted delivery of metal-based drugs

Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy

Engineered exosomes from different sources for cancer-targeted therapy

Engineered Extracellular Vesicles for Cancer Therapy

Engineered Extracellular Vesicle-Encapsuled Nanoreactors for Effective Targeting and Cascade Killing of Cancer Cells.

Advances in engineered exosomes towards cancer diagnosis and therapeutics

Engineering and Targeting Neutrophils for Cancer Therapy

A neutrophil mimicking metal-porphyrin-based nanodevice loaded with porcine pancreatic elastase for cancer therapy

Engineered Exosomes-Based Photothermal Therapy with MRI/CT Imaging Guidance Enhances Anticancer Efficacy through Deep Tumor Nucleus Penetration

A drug delivery platform using engineered MUC1‐targeting exosomes enhances chemosensitivity and immunogenic cell death in pancreatic ductal adenocarcinoma

Responsive Exosome Nano‐bioconjugates for Synergistic Cancer Therapy

Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer.

Exosomes As Actively Targeted Nanocarriers for Cancer Therapy

Hydrogel-Mediated Jamming of Exosome Communications That Counter Tumor Adaption in the Tumor Immune Microenvironment

Engineered Exosomes as Theranostic Platforms for Cancer Treatment

Roles of Mesenchymal Stem Cell-Derived Exosomes in Cancer Development and Targeted Therapy

Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence

An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments